Terms: = Ovarian cancer AND GATA3, HDR, 2625, ENSG00000107485, MGC5445, MGC5199, MGC2346
123 results:
1. Mesonephric-like adenocarcinoma of the ovary.
Yang Y; Zhao M; Jia Q; Tang H; Xing T; Li Y; Tang B; Xu L; Wei W; Zheng H; Shi R; Xia B; Chen J
J Ovarian Res; 2024 Mar; 17(1):57. PubMed ID: 38444000
[TBL] [Abstract] [Full Text] [Related]
2. Invasive micropapillary carcinoma of the breast and bilateral ovarian mature cystic teratoma with benign Brenner tumor in a postmenopausal woman - An uncommon occurrence.
Ayyanar P; Mitra S; Imaduddin M; Muduly DK
Indian J Pathol Microbiol; 2024; 67(1):189-191. PubMed ID: 38358219
[TBL] [Abstract] [Full Text] [Related]
3. ovarian non-gestational placental site trophoblastic tumor with lung metastasis: further evidence for a distinct category of trophoblastic neoplasm.
Shahi M; Katsakhyan L; Hopkins M; Allen-Rhoades W; Cepress MK; Langstraat C; Ishitani MB; Vang R; Ronnett BM; Xing D
Diagn Pathol; 2024 Jan; 19(1):3. PubMed ID: 38172961
[TBL] [Abstract] [Full Text] [Related]
4. Biallelic MAD2L1BP (p31comet) mutation is associated with mosaic aneuploidy and juvenile granulosa cell tumors.
Abdel-Salam GMH; Hellmuth S; Gradhand E; Käseberg S; Winter J; Pabst AS; Eid MM; Thiele H; Nürnberg P; Budde BS; Toliat MR; Brecht IB; Schroeder C; Gschwind A; Ossowski S; Häuser F; Rossmann H; Abdel-Hamid MS; Hegazy I; Mohamed AG; Schneider DT; Bertoli-Avella A; Bauer P; Pearring JN; Pfundt R; Hoischen A; Gilissen C; Strand D; Zechner U; Tashkandi SA; Faqeih EA; Stemmann O; Strand S; Bolz HJ
JCI Insight; 2023 Nov; 8(22):. PubMed ID: 37796616
[TBL] [Abstract] [Full Text] [Related]
5. DNA repair function scores for 2172 variants in the BRCA1 amino-terminus.
Diabate M; Islam MM; Nagy G; Banerjee T; Dhar S; Smith N; Adamovich AI; Starita LM; Parvin JD
PLoS Genet; 2023 Aug; 19(8):e1010739. PubMed ID: 37578980
[TBL] [Abstract] [Full Text] [Related]
6. Comprehensive Immunohistochemical Analysis of Mesonephric Marker Expression in Low-grade Endometrial Endometrioid Carcinoma.
Lee Y; Choi S; Kim HS
Int J Gynecol Pathol; 2024 May; 43(3):221-232. PubMed ID: 37566876
[TBL] [Abstract] [Full Text] [Related]
7. RAD51C-XRCC3 structure and cancer patient mutations define DNA replication roles.
Longo MA; Roy S; Chen Y; Tomaszowski KH; Arvai AS; Pepper JT; Boisvert RA; Kunnimalaiyaan S; Keshvani C; Schild D; Bacolla A; Williams GJ; Tainer JA; Schlacher K
Nat Commun; 2023 Jul; 14(1):4445. PubMed ID: 37488098
[TBL] [Abstract] [Full Text] [Related]
8. Trichorhinophalangeal Syndrome Type 1 Is a Highly Sensitive and Specific Marker for Diagnosing Triple-Negative Breast Carcinomas on Cytologic Samples.
Lynn TJ; Shi J; Liu H; Monaco SE; Prichard JW; Lin F
Arch Pathol Lab Med; 2024 Jan; 148(1):e1-e8. PubMed ID: 37406296
[TBL] [Abstract] [Full Text] [Related]
9. ovarian Mesonephric-Like Adenocarcinoma With Recurrent Liver Metastases: A Case Report with Analysis of Therapeutic Molecular Targets.
Sugitani A; Ogawa A; Yoshida H; Kobayashi-Kato M; Kikkawa N; Tanase Y; Uno M; Ishikawa M; Kato T
Int J Surg Pathol; 2024 May; 32(3):578-585. PubMed ID: 37345348
[TBL] [Abstract] [Full Text] [Related]
10. PRPF6 promotes metastasis and paclitaxel resistance of ovarian cancer via SNHG16/CEBPB/gata3 axis.
Wang H; Zhou Y; Zhang S; Qi YA; Wang M
Oncol Res; 2021; 29(4):275-289. PubMed ID: 37303939
[TBL] [Abstract] [Full Text] [Related]
11. Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51C.
Hu C; Nagaraj AB; Shimelis H; Montalban G; Lee KY; Huang H; Lumby CA; Na J; Susswein LR; Roberts ME; Marshall ML; Hiraki S; LaDuca H; Chao E; Yussuf A; Pesaran T; Neuhausen SL; Haiman CA; Kraft P; Lindstrom S; Palmer JR; Teras LR; Vachon CM; Yao S; Ong I; Nathanson KL; Weitzel JN; Boddicker N; Gnanaolivu R; Polley EC; Mer G; Cui G; Karam R; Richardson ME; Domchek SM; Yadav S; Hruska KS; Dolinsky J; Weroha SJ; Hart SN; Simard J; Masson JY; Pang YP; Couch FJ
Cancer Res; 2023 Aug; 83(15):2557-2571. PubMed ID: 37253112
[TBL] [Abstract] [Full Text] [Related]
12. An Attempt to Stretch the Benefit: Rechallenge with PARP Inhibitors in ovarian cancer.
Gonzalez-Ochoa E; Oza AM
Clin Cancer Res; 2023 Jul; 29(14):2563-2566. PubMed ID: 37191665
[TBL] [Abstract] [Full Text] [Related]
13. High-grade serous ovarian carcinoma with a sertoliform pattern associated with BRCA mutation: a clinicopathological and molecular analysis.
Travaglino A; Santoro A; Arciuolo D; Raffone A; Scaglione G; D'Alessandris N; Valente M; Sfregola S; Fulgione C; Onori ME; Minucci A; Zannoni GF
Virchows Arch; 2023 Dec; 483(6):879-883. PubMed ID: 37166561
[TBL] [Abstract] [Full Text] [Related]
14. Extrauterine Mesonephric-like Carcinoma: A Comprehensive Single Institution Study of 33 Cases.
Euscher ED; Marques-Piubelli ML; Ramalingam P; Wistuba I; Lawson BC; Frumovitz M; Malpica A
Am J Surg Pathol; 2023 Jun; 47(6):635-648. PubMed ID: 37026792
[TBL] [Abstract] [Full Text] [Related]
15. Vorinostat decrease M2 macrophage polarization through ARID1A
Hsieh TH; Hsu CY; Wu CW; Wang SH; Yeh CH; Cheng KH; Tsai EM
Biomed Pharmacother; 2023 May; 161():114500. PubMed ID: 36958195
[TBL] [Abstract] [Full Text] [Related]
16. [A Case of De Novo Stage Ⅳ Breast cancer with Umbilical Metastasis and Peritoneal Dissemination].
Mitsuyoshi A; Yanagawa T; Kikumori K; Hori A; Oshima K; Shinke G; Katsuyama S; Ikeshima R; Hiraki M; Ohmura Y; Sugimura K; Masuzawa T; Hata T; Takeda Y; Murata K
Gan To Kagaku Ryoho; 2023 Mar; 50(3):366-368. PubMed ID: 36927911
[TBL] [Abstract] [Full Text] [Related]
17. Mesonephric-like adenocarcinoma of the ovary with squamoid morular metaplasia, aberrant β-catenin expression, and concurrent FGFR2 and CTNNB1 mutations: a case report.
Xu J; Park KJ; Rehrauer WM; Weisman PS
Virchows Arch; 2024 Jan; 484(1):147-150. PubMed ID: 36856760
[TBL] [Abstract] [Full Text] [Related]
18. One biopsy, two tumors: A case report of collision tumor consisting in breast and endometrioid carcinoma detected on bioptic sample of peritoneal carcinomatosis.
Inzani F; Arciuolo D; Monterossi G; Quagliozzi L; Travaglino A; Santoro A; Valente M; D'Alessandris N; Scaglione G; Sfregola S; Cianfrini F; Zannoni GF
Pathol Res Pract; 2023 Mar; 243():154378. PubMed ID: 36812738
[TBL] [Abstract] [Full Text] [Related]
19. Mesonephric Adenomyofibroma: A Biphasic Vaginal Mass of Mesonephric Type With Molecular Analysis: A Case Report of a Rare Entity.
Shahi M; Palsgrove DN; Ronnett BM; Lin J; Murdock TA
Int J Gynecol Pathol; 2023 Sep; 42(5):523-528. PubMed ID: 36811844
[TBL] [Abstract] [Full Text] [Related]
20. Detection of Circulating Tumor Cell-Related Markers in Gynecologic cancer Using Microfluidic Devices: A Pilot Study.
Law KS; Huang CE; Chen SW
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768623
[TBL] [Abstract] [Full Text] [Related]
[Next]
